May
19
RARITAN, N.J., and TORONTO, Canada - A new prescription option is now available to the more than 50 million Americans who suffer from moderate to moderately severe chronic pain. Ortho-McNeil, Inc. and Biovail Corporation (NYSE:BVF) today announced that once-daily ULTRAM(R) ER (tramadol HCl) extended-release tablets are now available by prescription... (Source: Drug Newswire)
